Tor D Tosteson, Sc.D.
Professor of Community and Family Medicine
Professor of The Dartmouth Institute
Director, Division of Biostatistics, Department of Biomedical Data Science
Community and Family Medicine
The Dartmouth Institute
Biostatistics, Harvard University, SCD 1987
Biostatistics, Harvard University, MS 1980
Economics, University of North Carolina - Chapel Hill, BA 1975
Norris Cotton Cancer Center
The Dartmouth Institute for Health Policy and Clinical Practice
Dartmouth Medical School
Hanover NH 03755
My current research interests revolve around challenging methodological and statistical problems in biomedical data science. I collaborate extensively in the areas of cancer and musculoskeletal disease involving clinical, translational and outcomes research. I develop related statistical methodology in the areas of covariate measurement error for nonlinear regression models, clinical trials, and joint modeling of survival and longitudinal patient outcomes.
2R25CA134286 Training Program for Quantitative Population Sciences in Cancer (T.Tosteson)
5P60AR062799 Methodology Core (T.Tosteson)
5P60AR062799 Outcomes Calculators For Informed Decision Making In Back Surgery (T.Tosteson)
QBS Fundamentals of Biostatistics I & II; SYNERGY Certificate Program.
Prior to coming to Dartmouth, I spent 5 years on the faculties of Harvard Medical School at the Channing Laboratory, and Harvard School of Public Health in the Department of Biostatistics. I was elected as a Fellow of the American Statistical Association in 2014.
A Pilot Study of Ultrasound-Guided Cryoablation of Invasive Ductal Carcinomas up to 15 mm With MRI Follow-Up and Subsequent Surgical Resection.
Evaluation of an Automated Information Extraction Tool for Imaging Data Elements to Populate a Breast Cancer Screening Registry.
Using instrumental variables to estimate a Cox's proportional hazards regression subject to additive confounding.
Magnetic resonance imaging predictors of surgical outcome in patients with lumbar intervertebral disc herniation.
Joint modeling quality of life and survival using a terminal decline model in palliative care studies.
Geographic and sociodemographic disparities in PET use by Medicare beneficiaries with cancer.
Longitudinal structural mixed models for the analysis of surgical trials with noncompliance.
Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?
Surgery for lumbar degenerative spondylolisthesis in Spine Patient Outcomes Research Trial: does incidental durotomy affect outcome?
Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer?